Highlights
A collection of news and information related to Roche Holding AG published by this site and its partners.
Displaying items 1-12 of 26
» View wsbt.com items only
1
2
3
•
Next >
-
Lilly halts Alzheimer's drug trial due to liver problems
Reuters(Reuters) - Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to find a treatment that can slow or cure the memory-robbing...Tags: Trials, Lilly Eli & Co, Alzheimer's Disease, Diseases and Illnesses, Merck & Company Incorporated
-
As top court invalidates some gene patents, biotech has moved on
ReutersBy Sharon Begley NEW YORK, June 13 (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial...Tags: Science and Technology, Pharmaceuticals, Myriad Genetics Incorporated, Biotechnology, Patents, Copyrights and Trademarks
-
Roche's Avastin extends life in advanced cervical cancer
ReutersBy Bill Berkrot June 3 (Reuters) - Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way to another major use for the multibillion-...Tags: Trials, Chemotherapy, Oncology, Science and Technology, Drugs and Medicines
-
Roche's Avastin fails to prolong survival in brain cancer study
ReutersBy Bill Berkrot June 2 (Reuters) - The widely used Roche Holding AG cancer drug Avastin failed to prolong survival when added to chemo-radiation therapy for glioblastoma - a fast-growing type of brain tumor - according to data presented on Sunday....Tags: High Blood Pressure, Chemotherapy, Science and Technology, Drugs and Medicines, Breast Cancer
-
Wall Street posts first weekly loss since mid-April on Fed angst
ReutersNEW YORK (Reuters) - The S&P 500 declined for a third day on Friday, with the three major stock indexes posting their first negative week since mid-April on lingering concern that the central bank may scale back its stimulus measures to support the...Tags: Wal-Mart Stores, Inc., Tyson Foods Incorporated, Alternative Energy, Pain Therapeutics, Energy Saving
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Chemotherapy, Bristol Myers Squibb Company, HIV, Science and Technology, Weather Reports
-
Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: GlaxoSmithKline PLC, Novartis AG, Bristol Myers Squibb Company, AstraZeneca Plc, Citigroup Incorporated
-
Market Chatter-Corporate finance press digest
ReutersMay 22 (Reuters) - The following corporate finance-related stories were reported by media on Wednesday: * Australia's Westfield Group is in talks to sell seven U.S. shopping malls to private real estate investment company Starwood Capital Group for more...Tags: Economy, Business and Finance, European Union, Real Estate Buyers, Australia, Chevron Corportion
-
Roche, Sigma teamed up for failed Life Technologies bid -sources
ReutersBy Soyoung Kim and Greg Roumeliotis NEW YORK, May 21 (Reuters) - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said. Life Tech, the genetic...Tags: Illumina, Inc., Medical Research, Sigma-Aldrich Corporation
-
New cancer tools allow patients to reconsider chemo
ReutersLOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...Tags: Genomic Health Incorporated, Customs and Tradition, Breast Cancer, Washington Hospital Center, Medical Specialization
-
Bill would regulate 'biosimilar' drugs
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Tags: Exports, Food and Drug Administration, Jerry Hill, Pharmaceuticals, U.S. Senate Committee on Appropriations
-
Thermo Fisher To Buy Life Tech For $13.6 Billion
Thermo Fisher Scientific Inc. on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing. The pact values Life Tech at $76 per share, a 12 percent...Tags: Illumina, Inc., Companies and Corporations, Economy, Business and Finance, Blackstone Group, L.P., Science and Technology
Jun 13, 2013
|Story| Reuters
Jun 13, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 2, 2013
|Story| Reuters
May 24, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 12, 2013
|Story| Los Angeles Times
Apr 16, 2013
|Story| Hartford Courant
Original site for Roche Holding AG topic gallery.